AMGEN
USPTO Trademark Record · Serial No. 75146659
Trademark details
It was initially claimed by Amgen Inc. on 19960807.
That brand applies to the following goods and services:pharmaceutical preparations, namely, erythropoietin for use in treating chronic anemia, granulocyte colony stimulating factor and granuloctye-macrophage colony stimulating factor for use in restoring the level of white blood cells, [ hepatitis B vaccine, ] interferon and interleukin 2 for use in anticancer and antiviral applications, epidermal growth factor and platelet derived growth * factor * for use in treating surgical or soft tissue damage; [ and pharmaceutical preparations for animal heal.
Currently that trademark is represented by trademark attorney(s): Mark I. Feldman, Christina L. Martini.
You can learn more about that trademark on the USPTO website: View the USPTO record
Services available
Questions about this trademark?
If you have questions or issues related to the AMGEN trademark — or to trademarks in general — our trademark attorneys can help. No appointment needed: call us or request a free estimate.
Register a Trademark Get a Free Estimate
